Warfarin

Approval of new blood-thinner put on hold

  • Tue, 06/26/2012 - 4:04pm

Pfizer Inc. and Bristol-Myers Squibb struggle to gain FDA approval for blood thinner Eliquis, a drug used to treat heart arrhythmia.

Warfarin alternatives create concerns

  • Fri, 06/22/2012 - 2:59pm

Pradaxa and Xarelto are blood thinners and alternatives to warfarin that cause concerns for heart doctors.   

Study compares dabigatran to warfarin in treating blood clots

  • Fri, 06/08/2012 - 12:31pm

A study headed by Boehringer Ingelheim, the maker of Pradaxa, suggests a fixed dose of dabigatran therapy twice daily

Study compares dabigatran to warfarin in VTE treatment

  • Tue, 05/29/2012 - 11:06am

A study conducted primarily by Boehringer Ingelheim, the maker of Pradaxa, suggests a fixed dose of dabigatran therapy

Pradaxa Internal Bleeding Lawsuit - Consumer Drug Report

Study compares Pradaxa to warfarin

A new study, published in the Journal of the American College of Cardiology, compared the side

Pages